Descriptive characteristics of the final review studies.

<p>Descriptive characteristics of the final review studies.</p

The adjusted^* association between the self-reported outcome variables and non-odor related explanatory variables in communities near AFOs.

<p>*</p><p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009530#pone.0009530-Hoopmann1" target="_blank">[42]</a> Adjusted for gender, oldest sibling, experienced street noise (clearly vs. very little), actual smoking (yes vs. no), education level, breastfed at least 4 months (yes vs. no), mold (yes vs. no), contact with cats at a young age (yes vs. no), rug/Carpeted floor (yes vs. no), parental atopy.</p><p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009530#pone.0009530-Mirabelli2" target="_blank">[68]</a> Adjusted for individual-level characteristics (gender, age, race, Hispanic ethnicity, economic status, smoking status, exposure to second-hand smoke at home, and use of a gas stove more than once per month) and school-level characteristics (rural locale, indoor air quality, and reports of other non-livestock industries nearby).</p><p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009530#pone.0009530-Radon3" target="_blank">[62]</a> Adjusted for age (5 categories), sex, active and passive smoke exposure, level of education, number of siblings, parental allergies.</p><p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009530#pone.0009530-Avery1" target="_blank">[69]</a> Adjusted for fixed effects for odor, time of day, and day, and random effects for cluster, person within cluster, odor, and time of day.</p><p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009530#pone.0009530-Schiffman3" target="_blank">[65]</a> Two-way analysis of variance.</p

Frequency of description of design elements and design element options in the two preclinical datasets evaluated (CAMARADES (brain trauma/stroke) and toxicology).

<p>Frequency of description of design elements and design element options in the two preclinical datasets evaluated (CAMARADES (brain trauma/stroke) and toxicology).</p

Design element groups and annotation options for use with an AFLEX (automatic functional language recognition/EXtraction) interface for annotating portable document format files.

<p>Design element groups and annotation options for use with an AFLEX (automatic functional language recognition/EXtraction) interface for annotating portable document format files.</p

Development of IPDASi versions and IPDASi-SF: item retention and dimension merging.

*<p>IPDASi v1 is equivalent to the IPDAS Checklist.</p>¶<p>Test dimension items applicable to relevant DSTs.</p

IPDASi v3 Dimensions and Items.

<p>IPDASi v3 Dimensions and Items.</p

Thirty sampled decision support technologies: sample characteristics and adjusted full IPDASi (v3) ^* and SF scores based on duplicate assessment, with 95% confidence limits.

*<p>Adjusted scores: scores from the two raters were adjusted to take account of their personal propensity to give higher or lower scores. Components of variation were modelled by Bayesian modelling (Markov chain Monte Carlo) using WinBugs software, leading to estimated confidence intervals.</p><p><b>Abbreviations</b>: (APCC: Australian Prostate Cancer Collaboration; Barratt, UoS: University of Sydney; Crouch, Baylor: Baylor College of Medicine; Col, CORE: Center for Outcomes Research and Evaluation; Elwyn, CU: Cardiff University; FIMDM: Foundation for Informed Medical Decision Making; Lawrence, STVHCS: South Texas Veterans Health Care System; Leighl, UoT: University of Toronto; MCC: Michigan Cancer Consortium Prostate Cancer Action Committee; MIDIRS: Midwife Information and Resource Service; NERI: New England Research Institutes; OHDeC: Ottawa Health Decision Centre; Shorten, ACM: Australian College of Midwives; Taylor, GU: Georgetown University; US CDC: Centers for Disease Control and Prevention; Wakefield MU, Macquarie University).</p